VIC 2022 Mid-Year Update Executive Summary

The first half of the year has been exciting for VIC and our portfolio companies, including new pre-clinical and clinical milestones reached, products released to market, recent funding, and more

Click Here to download The Mid-Year Report - Executive Summary or view it below.

2022_MidYearUpdate_Summary 1

2022_MidYearUpdate_Summary 2

2022_MidYearUpdate_Summary 3

2022_MidYearUpdate_Summary 4

2022_MidYearUpdate_Summary 5

2022_MidYearUpdate_Summary 6

2022_MidYearUpdate_Summary 72022_MidYearUpdate_Summary 82022_MidYearUpdate_Summary 92022_MidYearUpdate_Summary 102022_MidYearUpdate_Summary 11

2022_MidYearUpdate_Summary 12To learn more visit,